FDA NDC Directory · JSON-LD · Markdown

Mesalamine

NDC 0378-1375 · HUMAN PRESCRIPTION DRUG · CAPSULE, EXTENDED RELEASE

Generic namemesalamine
Labeler / ManufacturerMylan Pharmaceuticals Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA207271
Dosage form / routeCAPSULE, EXTENDED RELEASE · ORAL
Active ingredientsMESALAMINE (.375 g/1)
Marketing started20191126
Package count1

External sources

Source: openFDA. Public-domain (CC0).